Trial Profile
A Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haploidentical Peripheral Blood Stem Cell Transplantation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Mycophenolate mofetil (Primary) ; Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Busulfan; Fludarabine; Granulocyte colony-stimulating factors; Granulocyte colony-stimulating factors
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 13 Apr 2021 Status changed from active, no longer recruiting to completed.
- 04 Feb 2021 Planned End Date changed from 1 Jan 2021 to 1 Jan 2022.
- 17 Sep 2018 Status changed from recruiting to active, no longer recruiting.